Abstract
Acute sickle cell intrahepatic cholestasis (SCIC) is a rare but usually fatal complication of sickle cell disease (SCD), which has mostly been described in homozygous for hemoglobin S patients. It is characterized by acute hepatomegaly, striking jaundice, bleeding diathesis and increasing encephalopathy [ 1 Banerjee S Owen C Chopra S Sickle cell hepatopathy. Hepatology. 2001; 33: 1021-1028 Crossref PubMed Scopus (126) Google Scholar , 2 Khurshid I Anderson L Downie G.H Pape G.S Sickle cell disease, extreme hyperbilirubinemia, and pericardial tamponade: case report and review of the literature. Crit Care Med. 2002; 30: 2363-2367 Crossref PubMed Scopus (28) Google Scholar ]. On the other hand, hepatitis C virus (HCV) infection is common (up to 30.3%) among transfused patients with SCD [ 1 Banerjee S Owen C Chopra S Sickle cell hepatopathy. Hepatology. 2001; 33: 1021-1028 Crossref PubMed Scopus (126) Google Scholar , 3 Hasan M.F Marsh F Posner G Bellevue R Dosik H Suatengco R et al. Chronic hepatitis C in patients with sickle cell disease. Am J Gastroenterol. 1996; 91: 1204-1206 PubMed Google Scholar ]. However, the development of acute SCIC in an HCV infected patient with s/β+ thalassaemia has never been reported previously.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
